Fennec Pharmaceuticals In...

NASDAQ: FENC · Real-Time Price · USD
8.27
-0.09 (-1.08%)
At close: Aug 18, 2025, 3:59 PM
8.20
-0.85%
After-hours: Aug 18, 2025, 04:10 PM EDT

Fennec Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
47.54M 21.25M 1.53M n/a
Cost of Revenue
3.18M 1.26M 86K n/a
Gross Profit
44.35M 19.99M 1.45M n/a
Operating Income
2.57M -12.77M -22.59M -17.22M
Interest Income
1.59M 441K 195K 54K
Pretax Income
-71K -16.05M -23.71M -17.35M
Net Income
-436K -16.05M -24.84M -17.46M
Selling & General & Admin
41.48M 32.71M 20.51M 12.24M
Research & Development
307K 56K 3.53M 4.98M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
41.79M 32.76M 24.04M 17.22M
Interest Expense
4.07M 3.39M 978K 126K
Selling & Marketing Expenses
18.43M 12.12M 2.79M n/a
Cost & Expenses
44.97M 34.02M 24.12M 17.22M
Income Tax Expense
365K n/a 1.13M 110K
Shares Outstanding (Basic)
27.29M 26.57M 26.27M 26.01M
Shares Outstanding (Diluted)
27.29M 26.57M 26.27M 26.01M
EPS (Basic)
-0.02 -0.6 -0.95 -0.67
EPS (Diluted)
-0.02 -0.6 -0.95 -0.67
EBITDA
3.6M -12.36M -22.59M -123K
EBIT
2.57M -12.65M -22.74M -17.07M
Depreciation & Amortization
1.03M 287K 149K 17.22M